The Association of Clinical Research Organizations, which represents the CRO industry globally, is pleased to announce that Chiltern, headquartered in Berkshire, United Kingdom, has joined ACRO and that Glenn Kerkhof, Chiltern CEO, will be the company's representative to the Association.
“ACRO's membership is expanding internationally just as our focus is increasingly global in scale”
"We welcome Chiltern into ACRO and look forward to exchanging views and perspectives with Glenn as he represents one of the larger European-based CROs," said William Sharbaugh, ACRO Chair and COO of PPD.
Established in 1982, Chiltern is a leading global CRO with extensive experience conducting and staffing Phase I to Phase IV clinical trials. The company employs more than 1,400 people within 19 countries.
"ACRO's membership is expanding internationally just as our focus is increasingly global in scale," said Doug Peddicord, Ph.D., ACRO Executive Director. "We invite all CROs with global aspirations to demonstrate their commitment to the industry by joining ACRO."
SOURCE Association of Clinical Research Organizations (ACRO)
Microfluidic chips advance neurodegenerative disease research